Caffeine for Hypoxic Ischemic Encephalopathy

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

830

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

December 31, 2029

Study Completion Date

July 31, 2030

Conditions
Hypoxic Ischemic Encephalopathy (HIE)
Interventions
DRUG

Caffeine citrate oral solution

Caffeine citrate oral solution will be used and administered by enteral route (oral or by gavage tube). The loading dose (20 mg/kg) will be administered once followed by daily doses of 10 mg per kg body weight every 24 hours for two doses. The study Standard Operating Procedures (SOPs) includes details regarding caffeine preparation based on the participant's body weight.

DRUG

Oral placebo solution

Identical placebo oral solution

Trial Locations (7)

Unknown

ICDDR,B, Saidpur

Kinshasa School of Public Health, Kinshasa

Institute of Nutrition of Central America And Panama (INCAP), Chimaltenango

KLE University's J N Medical College, Belagavi

Lata Medical Research Foundation, Nagpur

Aga Khan University, Karachi

University Teaching Hospital, Lusaka

All Listed Sponsors
collaborator

RTI International

OTHER

collaborator

University of North Carolina, Chapel Hill

OTHER

collaborator

Kinshasa School of Public Health

OTHER

collaborator

Institute of Nutrition of Central America and Panama (INCAP)

UNKNOWN

collaborator

Lata Medical Research Foundation, Nagpur

OTHER

collaborator

Aga Khan University

OTHER

collaborator

University Teaching Hospital, Lusaka, Zambia

OTHER

collaborator

KLE Academy of Higher Education and Research (Deemed- to- be-University), Jawaharlal Nehru Medical College (JNMC), Belagavi, India

UNKNOWN

collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

University of Virginia

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

Thomas Jefferson University

OTHER

collaborator

Columbia University

OTHER

collaborator

University of Colorado, Denver

OTHER

collaborator

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

lead

NICHD Global Network for Women's and Children's Health

NETWORK